Evaluation of dedicated infectious diseases pharmacists on antimicrobial stewardship teams

American Journal of Health-System Pharmacy

Volumn 71, Issue 12, 2014, Pages 1019-1028

  Yu, Kalvin ^a   Rho, Jay ^b   Morcos, Marlene ^c   Nomura, Jim ^c   Kaplan, Donald ^d   Sakamoto, Keith ^a   Bui, Doan ^c   Yoo, Sandy ^c   Jones, Jason ^e  

^a West Los Angeles Medical Center   (United States)

^b KP   (United States)

^c LOS ANGELES MEDICAL CENTER   (United States)

^d KP National Pharmacy Programs and Services   (United States)

^e Clinical Intelligence and Decision Support   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPOFUNGIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; DAPTOMYCIN; ERTAPENEM; FLUCONAZOLE; LINEZOLID; MEROPENEM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; VORICONAZOLE; ANTIINFECTIVE AGENT;

ANTIMICROBIAL STEWARDSHIP PROGRAM; ANTIMICROBIAL THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE QUALITY; HEALTH PROGRAM; HOSPITAL STANDARDIZED MORTALITY RATIO; HUMAN; INFECTION; INFECTION RATE; MEDICARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OUTCOME ASSESSMENT; PATIENT CARE; PHARMACIST; PHYSICIAN; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SEPSIS; STANDARDIZED MORTALITY RATIO; TREATMENT DURATION; COMMUNICABLE DISEASES; ECONOMICS; HOSPITAL; HOSPITAL PHARMACY; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; STANDARDS;

ANTI-INFECTIVE AGENTS; COMMUNICABLE DISEASES; COST SAVINGS; DRUG COSTS; HOSPITALS; HUMANS; PATIENT CARE; PATIENT CARE TEAM; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; RETROSPECTIVE STUDIES;

EID: 84907214503     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp130612     Document Type: Article

References (30)

1. Blázquez J, Couce A, Rodríguez-Beltrán J et al. Antimicrobials as promoters of genetic variation. Curr Opin Microbiol. 2012; 15:561-9.
2. Carling P, Fung T, Killion A et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003; 24:699-706.
3. LaRocco A. Concurrent antibiotic review programs - a role for infectious diseases specialists at small community hospitals. Clin Infect Dis. 2003; 37:742-3.
4. Ruttimann S, Keck B, Harmeier C et al. Longterm antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004; 38:348-56.
5. Lutters M, Harbarth S, Janssens JP et al. Effect of a comprehensive, multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J Am Geriatr Soc. 2004; 52:112-6.
6. Goff D. Antimicrobial stewardship: bridging the gap between quality care and cost. Curr Opin Infect Dis. 2011; 24(suppl 1):S11-20.
7. Goff D, Bauer R, Mangino J. Antimicrobial stewardship management of infections: beyond the costs of antimicrobials. Pharm Pract News. 2012; Aug:45-56.
8. MacDougall C, Polk R. Antimicrobial stewardship programs in health care systems. Clin Micro Rev. 2005; 18:638-56.
9. Infectious Diseases Society of America. Infection prevention and control of health care-associated infections. www.idsociety.org/Infection-Control-Policy/ (accessed 2013 May).
10. Joint Commission. 2009 National Patient Safety Goals. www.jointcommission.org/standards-information/npsgs.aspx (accessed 2013 May 15).
11. California Department of Public Health. Healthcare Associated Infections (HAI) Program. www.cdph.ca.gov/programs/hai/Pages/AntimicrobialStewardshipProgramInitiative.aspx (accessed 2013 May 15).
12. Centers for Medicare and Medicaid Services. Interpretive guidelines for long-term care facilities. Tag F441. www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107ap-pp-guidelines-ltcf.pdf (accessed 2014 Mar 5).
13. Dellit T, Owens R, McGowan J Jr et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44:159-77.
14. Patel D, Lawson W, Guglielmo J. Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev Infect Ther. 2008; 6:209-22.
15. MacKenzie FM, Gould IM, Bruce J et al. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. J Hosp Infect. 2007; 65(suppl 2):73-81.
16. Davey P, Brown E, Charani E et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013; 4:CD003543.
17. Ansari F, Gray K, Nathwani D et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother. 2003; 52:842-8.
18. Gross R, Morgan A, Kinky D et al. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis. 2001; 33:289-95.
19. Bantar C, Sartori B, Vesco E et al. A hospital-wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis. 2003; 37:180-6.
20. Belongia E, Knobloch M, Kieke B et al. Impact of statewide program to promote appropriate antimicrobial drug use. Emerg Infect Dis. 2005; 11:912-20.
21. Marrie T, Lau C, Wheeler S et al. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA. 2000; 283:749-55.
22. Kruster S, Ruef C, Ledergerber B et al. Quantitative antibiotic use in hospitals: comparison of measurements, literature review, and recommendations for a standard of reporting. Infection. 2008; 36:549-59.
23. Trivedi K, Rosenberg J. The state of antimicrobial stewardship programs in California. Infect Control Hosp Epidiol. 2013; 34:379-84.
24. Wickens HJ, Farrell S, Ashiru-Oredope DA et al. The increasing role of pharmacists in antimicrobial stewardship in English hospitals. J Antimicrob Chemother. 2013; 68:2675-81.
25. World Health Organization. Guidelines for ATC classification and DDD assignments. 16th ed. www.whocc.no/filearchive/publications/1-2013guidelines.pdf (accessed 2013 May 15).
26. Centers for Disease Control and Prevention. National Healthcare Safety Network (NHSN). www.cdc.gov/nhsn/ (accessed 2013 May 15).
27. Lidia K, Pierre-Yves B, Lulla O et al. Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant S. aureus. Antimicrob Agents Chemother. 2013; 57:4410-6.
28. Novak-Weekley S, Marlowe E, Miller J et al. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol. 2010; 48:889-93.
29. Fong K, Fatica C, Hall G et al. Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? Infect Control Hosp Epidemiol. 2011; 32:932-3.
30. Joint Commission. Surgical Care Improvement Project. www.jointcommission.org/surgical-care-improvement-project/ (accessed 2013 Dec).